Cannabinoids and opioid consumption in cancer pain: a systematic review and meta-analysis
Abstract Background: Opioids are the mainstay of cancer-related pain management but are limited by adverse effects and clinical complexity. Cannabinoids…
Abstract Background: Opioids are the mainstay of cancer-related pain management but are limited by adverse effects and clinical complexity. Cannabinoids…
Abstract Introduction and Aim: Assessment of antitumor activity in preclinical models remains challenging when relying solely on conventional size-based imaging,…
Abstract Introduction: Cannabinoids hold promise in oncology for symptom relief and antitumor effects, though concerns about safety and efficacy persist.…
Abstract Chemotherapy-induced neuropathic pain (CINP), a condition with unmet treatment needs, affects over half of cancer patients treated with chemotherapeutics.…
Abstract Introduction: Chemotherapy-induced peripheral neuropathy (CIPN) is a shared burden for 68.1% of oncological patients undergoing chemotherapy with Paclitaxel (PTX).…
Abstract Cannabis enjoyed a “golden age” as a medicinal product in the late 19th, early 20th century, but the increased…
Abstract The endocannabinoid system (ECS) dynamically regulates many aspects of mammalian physiology. ECS has gained substantial interest since growing evidence…
Abstract The most important discoveries in pharmacology, such as certain classes of analgesics or chemotherapeutics, started from natural extracts which…
Abstract Cannabis has been used in pain management since 2900 BC. In the 20th century, synthetic cannabinoids began to emerge,…